Pixels & Pills

Entries Tagged as 'Trends'

What Pharma Could Learn from Mad Men

January 20th, 2012 · 1 Comment · Opinion

by Jason Brandt (@jasondmg3)
Mad Men protagonist Don Draper works in the show’s fictional advertising agency, but the challenges he faces are real, and not much different than what many healthcare marketers face on a daily basis – meeting deadlines, incorporating new technologies, managing perceptions, and influencing behaviors all while ensuring personal growth.
The pharmaceutical industry and [...]

Share

[Read more →]

Tags:···········

Lean Digital Strategy

January 19th, 2012 · No Comments · Opinion, Trends

by Jason Brandt (@jasondmg3)
Can two of the hottest organizational and operational trends from the last 20 years – Lean Manufacturing and Six Sigma – be adapted to pharma? That’s a trick question: They already have been, and quite successfully.
But, how about online pharma marketing? It’s a more interesting proposition.
First, some definitions for the majority of [...]

Share

[Read more →]

Tags:···········

Making the Case for Mobile in Healthcare

January 18th, 2012 · 1 Comment · Trends

We’ve been writing a lot about the case for mobile in healthcare over the past couple of years. And we’re going to keep writing about it. With one quarter of US adults turning to their mobiles for healthcare information, it’s important that the industry keeps pushing forward with innovative sites, apps and tools that will [...]

Share

[Read more →]

Tags:············

Conversation: Darshan Kulkarni on the FDA Draft Guidance

January 17th, 2012 · No Comments · News, Opinion

Last week Pixels & Pills’ editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan Kulkarni (@FDALawyers) of the Kulkarni Law Firm in Philadelphia. And while the questions answered in the conversation don’t constitute legal advice and [...]

Share

[Read more →]

Tags:···············

Apps: HeartBeats for Android

January 16th, 2012 · No Comments · Knowledge, Trends

You’ve told us that you want to see more about what goes on at Zemoga, the sponsor of this media property, so we thought we’d give you a quick look in at a recent project that the team is especially proud of. Maria Rueda gave us the lowdown on one of Zemoga’s new babies, the [...]

Share

[Read more →]

Tags:·············

Life Sciences Innovation Forum

January 13th, 2012 · No Comments · News

We’ve entered conference season and there are a lot of great ones on the horizon in the next few weeks. Our friend John Mack has a fairly comprehensive list over on his website, but he’s missing one that we’re particularly excited about.
The Life Sciences Innovation Forum, from Microsoft and our friends at ExL Pharma, promises to addresses [...]

Share

[Read more →]

Tags:··········

Why Aren’t We Talking About H-Commerce?

January 12th, 2012 · 2 Comments · Knowledge, Opinion, Trends

By Sven Larsen
These days everyone is familiar with e-commerce. And our more social media savvy readers are probably all clued up on f-commerce (that’s Facebook commerce folks). I’ve even heard Google’s Adwords and Adsense business referred to as g-commerce. But what about the next letter in the alphabet. How come no one is talking about [...]

Share

[Read more →]

Tags:·············

POINT/COUNTERPOINT: Should You “Cross Streams” When You’re A Social Media Professional?

January 11th, 2012 · 1 Comment · Opinion

This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
In The [...]

Share

[Read more →]

Tags:··········

POINT/COUNTERPOINT: Should You “Cross Streams” When You’re A Social Media Professional?

January 10th, 2012 · No Comments · Opinion

This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Jason Brandt (@jasondmg3)
As Egon [...]

Share

[Read more →]

Tags:··········

In Light of FDA Draft Guidance? Keep Going

January 9th, 2012 · 8 Comments · Opinion, Trends

by Briana Campbell (@MsMatchGirl)
By now, you’ve all had time to review the FDA’s draft guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices. And you’ve had time to read the multitude of responses that came after (if you didn’t, Fabio Gratton has compiled many of them for you). And, [...]

Share

[Read more →]

Tags:·············